Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.
- Published In:
- ChemMedChem, 11(22), 2474-2495 (2016)
- Database ID:
- RPEP-03146
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03146APA
van Witteloostuijn, Søren B; Pedersen, Søren L; Jensen, Knud J. (2016). Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.. ChemMedChem, 11(22), 2474-2495. https://doi.org/10.1002/cmdc.201600374
MLA
van Witteloostuijn, Søren B, et al. "Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.." ChemMedChem, 2016. https://doi.org/10.1002/cmdc.201600374
RethinkPeptides
RethinkPeptides Research Database. "Half-Life Extension of Biopharmaceuticals using Chemical Met..." RPEP-03146. Retrieved from https://rethinkpeptides.com/research/van-2016-halflife-extension-of-biopharmaceuticals
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.